FDA Law Blog

NOVEMBER 1, 2023

The PR first sets out to establish that it has authority to regulate in vitro diagnostic “test systems” as devices, and not just the system’s individual components, such as reagents, instruments, specimen collection devices, and software. This comparison is misplaced.

In-Vitro 81

In-Vitro Regulation Manufacturing Licensing 81

pharmaphorum

JUNE 1, 2021

The dramatic rise in online drug sales during the COVID-19 pandemic has increased the supply of counterfeit drugs, and many companies are now considering the addition of on-dose authentication for high-risk or high-value products. This had led to a corresponding rise in the supply of counterfeit drugs.

Medicine 52

Medicine DNA Pharmacy Production 52

The Pharma Data

MAY 15, 2023

She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company. Shamiram holds an AB from Smith College and Doctor of Medicine as well as a Master of Public Health, both from Emory University, U.S.A. Prior to that, he worked in multiple executive business and finance roles for Philips and KPMG.

Sales 40

Sales Production Doctor Doctors 40